U.S. Markets close in 5 hrs, 22 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,982.08 | -76.56 | -0.76% |
| NASDAQ | 2,133.73 | -17.14 | -0.80% |
| S&P 500 | 1,061.23 | -9.29 | -0.87% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 19.40 10:12 AM EST | |
|---|---|---|
| Day High | 19.63 09:46 AM EST |
|
| Range | 0.23 |
| Volume | 105,882 | |
|---|---|---|
| 30-Day Avg Vol | 1.50 M |
|
| Difference | -92.98% |
| Market Cap | 2.27 B | |
|---|---|---|
| Mkt Cap Chg | -22.27 M |
| Shares Out | 117.25 M | |
|---|---|---|
| % Shrs Traded | 0.09% | |
| 1yr EPS Est | 2.731 |
| 52-Wk Low | 15.75 | |
|---|---|---|
| 52-Wk High | 24.10 |
|
| Range | 8.35 |
| Prev Close | 19.63 2/9/10 | |
|---|---|---|
| Today's Open | 19.55 | |
| Change | -0.41% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.11 M |
| Revenue (LFY) | 1.26 B | |
|---|---|---|
| Earnings (LFY) | 261.74 M | |
| Earnings (MRQ) | 49.42 M | |
| Next Earn Est | 0.681 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | 1.64 | |
| 1yr EPS Growth | 0.40% |
| P/E Ratio (TTM) | 11.57 | |
|---|---|---|
| P/E Ratio (Fwd) | 7.10 | |
| PEG Ratio | 0.75 | |
| Return on Equity | 19.50 | |
| Beta | 0.48 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Endo Pharmaceuticals wants the pain to end, preferably through the drugs it acquires and markets. The pharmaceutical company has a portfolio of both branded and generic prescription products for pain management. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.681 2/22/10 | — — |
—
—
|
| Last Quarter | 0.645 9/30/09 | 0.63 9/30/09 |
-0.015
Missed
|
| 2 Quarters Ago | 0.667 6/30/09 | 0.73 6/30/09 |
0.063
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 361.03 M | 1.26 B |
| Gross Profit | 263.72 M | 993.30 M |
| Operating Income | 64.11 M | 395.03 M |
| Net Income | 49.42 M | 261.74 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts